Eltrombopag Ethanolamine Dry Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Eltrombopag Ethanolamine Dry Suspension, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA [Phase 3]